American Strategic (NYSE:NYC) Stock, Quote.Headers.trade-ideas

American Strategic

American Strategic Investment Co is an externally managed company that currently owns a portfolio of commercial real estate located within the five boroughs of New York City, majorly Manhattan. The Company's real estate assets consist of office properties and certain real estate assets that accompany office properties, including retail spaces and amenities.

Earnings

Earnings Misses

Large Cap

News

Markets

Analyst Ratings

Trading Ideas

American Strategic Investment Co. (NYSE: NYC) came out with a quarterly loss of $2.84 per share versus the Zacks Consensus Estimate of a loss of $2.99. This compares to loss of $4.77 per share a year ago. These figures are adjusted for non-recurring items.

American Strategic Investment Co. Reports Q2 Loss, Lags Revenue Estimates

Image44

Long Ideas

Insider Trades

Intraday Update

ADVM

APPN

More Than $10M Bet On Appian? Check Out These 3 Stocks Insiders Are Buying

Movers

ADTN

AGRI

AIRE

AMBC

AORT

ATSG

AUDC

BAND

BLDR

BTBD

BYON

CMND

COKE

CROX

DAVE

DDOG

EVER

FGEN

FWRG

GLDD

GSUN

Hims & Hers Health, Inc. Class A Common Stock

HIMS

HSDT

JELD

JJSF

JMIA

LCID

MSGM

NUVO

NUWE

PLTN

PLTR

PRGO

REAX

SELF

SGRY

STIM

STRL

TALK

TWKS

ZETA

Why Beyond Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Tuesday&#39;s Mid-Day Session

American Strategic Investment Co. Class A Common Stock

American Strategic Investment Co

NewYorkCoin

New York Community Bancorp, Inc. Common Stock

New York Community Bancorp Inc

New York Community Bancorp, Inc. Depositary shares, each representing a 1/40th interest in a share of Fixed-to-Floating Rate Series A Noncumulative Perpetual Preferred Stock

New York Community Bancorp, Inc. New York Community Capital Tr V (BONUSES)

New York Community Capital Trust V

American Strategic Investment Co. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nyc#NYSE">NYC</a>) came out with a quarterly loss of $2.84 per share versus the Zacks Consensus Estimate of a loss of $2.99. This compares to loss of $4.77 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of 5.02%. A quarter ago, it was expected that this company would post a loss of $3.07 per share when it actually produced a loss of $3.28, delivering a surprise of -6.84%.
Over the last four quarters, the company has surpassed consensus EPS estimates just once.
American Strategic Investment Co., which belongs to the Zacks Real Estate - Operations industry, posted revenues of $15.75 million for the quarter ended June 2024, missing the Zacks Consensus Estimate by 1.92%. This compares to year-ago revenues of $15.78 million. The company has not been able to beat consensus revenue estimates over the last four quarters.
The sustainability of the stock&#39;s immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management&#39;s commentary on the earnings call.
American Strategic Investment Co. Shares have added about 9.7% since the beginning of the year versus the S&amp;P 500&#39;s gain of 11.5%.
<h2>What&#39;s Next for American Strategic Investment Co.</h2>
While American Strategic Investment Co. Has underperformed the market so far this year, the question that comes to investors&#39; minds is: what&#39;s next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company&#39;s earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for American Strategic Investment Co. Mixed. While the magnitude and direction of estimate revisions could change following the company&#39;s just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future.
It will be interesting to see how estimates for the coming quarters and current fiscal year change in the days ahead. The current consensus EPS estimate is -$3 on $16.2 million in revenues for the coming quarter and -$12.32 on $64.05 million in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Real Estate - Operations is currently in the bottom 32% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
UBS (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ubs#NYSE">UBS</a>), another stock in the broader Zacks Finance sector, has yet to report results for the quarter ended June 2024. The results are expected to be released on August 14.
This bank is expected to post quarterly earnings of $0.12 per share in its upcoming report, which represents a year-over-year change of -93.6%. The consensus EPS estimate for the quarter has been revised 24% lower over the last 30 days to the current level.
UBS&#39;s revenues are expected to be $11.42 billion, up 19.7% from the year-ago quarter.
<a href="https://www.zacks.com/stock/news/2319783/american-strategic-investment-co-nyc-reports-q2-loss-lags-revenue-estimates?cid=CS-BENZ-FT-tale_of_the_tape|yseop_template_4-2319783">To read this article on Zacks.com click here.</a>

American Strategic (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NYC#NYSE">NYC</a>) reported quarterly losses of $(2.84) per share which beat the analyst consensus estimate of $(2.99) by 5.02 percent. This is a 283.78 percent decrease over losses of $(0.74) per share from the same period last year. The company reported quarterly sales of $15.75 million which missed the analyst consensus estimate of $16.06 million by 1.91 percent. This is a 0.18 percent decrease over sales of $15.78 million the same period last year.

Earnings Beats

American Strategic Q2 Adj $(2.84) Beats $(2.99) Estimate, Sales $15.75M Miss $16.06M Estimate

Although U.S. stocks closed lower on Thursday, there were a few notable insider trades.
When insiders purchase shares, it indicates their confidence in the company&#8217;s prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.
Below is a look at a few recent notable insider purchases. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/">Benzinga&#8217;s insider transactions</a> platform.
<h3 class="wp-block-heading">Adverum Biotechnologies</h3>
<ul>
<li>The Trade: Adverum Biotechnologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADVM#NASDAQ">ADVM</a>) 10% owner Braden Michael Leonard <a href="https://www.benzinga.com/quote/ADVM/analyst-ratings">acquired a total of 216,264 shares</a> at an average price of $8.26. To acquire these shares, it cost around $1.79 million.</li>
<li>What's Happening: On July 17, Adverum Biotechnologies released data from its ongoing LUNA Phase 2 trial for Ixo-vec in patients with wet age-related macular degeneration (AMD).</li>
<li>What Adverum Biotechnologies Does: Adverum Biotechnologies Inc is a U.S.-based clinical-stage gene therapy company.</li>
</ul>
<h3 class="wp-block-heading">Appian</h3>
<ul>
<li>The Trade: Appian Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APPN#NASDAQ">APPN</a>) 10% owner Colin T. Moran acquired a total of 300,000 shares at &lt;/em&gt;&lt;/a&gt; an average price of $35.40. To acquire these shares, it cost around $10.6 million.</li>
<li>What's Happening: Appian will release financial results for the second quarter, before the opening bell on Thursday, Aug. 1.</li>
<li>What Appian Does: Appian is a low-code enterprise platform-as-a-service company focusing on business process management.</li>
</ul>
<h3 class="wp-block-heading">American Strategic Investment</h3>
<ul>
<li>The Trade: American Strategic Investment Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NYC#NYSE">NYC</a>) 10% owner New York City Advisors, LLC <a href="https://www.benzinga.com/sec/insider-trades/">bought a total of 125,864 shares</a> at an average price of $10.98. To acquire these shares, it cost around $1.38 million.</li>
<li>What's Happening: On May 10, the company posted downbeat quarterly sales.</li>
<li>What American Strategic Investment Does: American Strategic Investment Co is an externally managed company that currently owns a portfolio of commercial real estate located within the five boroughs of New York City, majorly Manhattan.</li>
</ul>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/24/07/39859847/netflix-to-rally-more-than-10-here-are-10-top-analyst-forecasts-for-friday">Netflix To Rally More Than 10%? Here Are 10 Top Analyst Forecasts For Friday</a></li>
</ul>

$11.00 Offer Represents $0.75 Per Share Increase in Offer Price to May 7, 2024 Tender Offer
NEW YORK, June 26, 2024 /PRNewswire/ --&nbsp;Bellevue Capital Partners, LLC ("Bellevue") announced today that it has increased the purchase price of its previously announced tender offer to purchase up to 125,000 shares of American Strategic Investment Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NYC#NYSE">NYC</a>) ("ASIC") common stock from the previous purchase price of $10.25 to an increased purchase price of $11.00 per share (the "Tender Offer"). The Tender Offer will close on July 5, 2024.

Bellevue Capital Partners Increases The Purchase Price For Its Previously Announced Tender Offer For Shares Of American Strategic Investment From $10.25 To $11 Per Share

Asset Sales

American Strategic Investment Co. Announced That It Has Agreed To A Term Sheet To Sell Its 9 Times Square Midtown Manhattan Property For $63.5M

WIIM

American Strategic Investment shares are trading higher after Bellevue Capital Partners announced it increased its purchase price of its previously announced tender offer for shares of the company.

The Tender Offer will close on&nbsp;July 5, 2024. The $10.25 offer represents $1.00 per share increase in offer price to may 7, 2024 tender offer. 
&nbsp;

Offerings

Bellevue Increases Purchase Price Of Its Previously Announced Tender Offer To Purchase Up To 125K Shares Of American Strategic Investment Common Stock From $9.25 To $10.25 Per Share

American Strategic (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NYC#NYSE">NYC</a>) reported quarterly losses of $(3.28) per share. This is a 43.15 percent increase over losses of $(5.77) per share from the same period last year. The company reported quarterly sales of $15.481 million which missed the analyst consensus estimate of $15.782 million by 1.91 percent. This is a 0.34 percent decrease over sales of $15.534 million the same period last year.

American Strategic Q1 2024 GAAP EPS $(3.28) Up From $(5.77) YoY, Sales $15.481M Miss $15.782M Estimate

Shares of Beyond, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BYON#NYSE">BYON</a>) fell sharply during Tuesday&#8217;s session following weaker-than-expected <a href="https://www.benzinga.com/quote/BYON">quarterly results</a>.
Beyond posted adjusted loss of $1.22 per share, versus estimates for a loss of 87 cents per share. The company&#8217;s sales came in at $382.281 million versus estimates of $389.264 million, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Beyond shares dipped 20.8% to $17.34 on Tuesday.
Here are some other stocks moving in today&#8217;s mid-day session.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Golden Sun Health Technology Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GSUN#NASDAQ">GSUN</a>) shares gained 94.7% to $5.60. Golden Sun Health Technology Group regained compliance with Nasdaq continued listing requirement.</li>
<li>MMTec, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTC#NASDAQ">MTC</a>) gained 79.1% to $4.1189.</li>
<li>Nuwellis, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUWE#NASDAQ">NUWE</a>) shares climbed 50.5% to $0.2572 after the company posted a narrower-than-expected quarterly loss.</li>
<li>Great Lakes Dredge &amp; Dock Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLDD#NASDAQ">GLDD</a>) rose 31.5% to $9.26 following better-than-expected first-quarter financial results.</li>
<li>American Strategic Investment Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NYC#NYSE">NYC</a>) jumped 29.6% to $7.52.</li>
<li>Motorsport Games Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSGM#NASDAQ">MSGM</a>) gained 29.2% to $2.9493. Motorsport Games is expected to report its financial results for the first quarter of 2024 on Tuesday, May 7.</li>
<li>FibroGen, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FGEN#NASDAQ">FGEN</a>) surged 28.7% to $1.4899 after the company reported mixed first quarter financial results.</li>
<li>Bioventus Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BVS#NASDAQ">BVS</a>) rose 26.7% to $5.07 after the company reported better-than-expected first-quarter financial results and raised its FY24 guidance above estimates.</li>
<li>reAlpha Tech Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIRE#NASDAQ">AIRE</a>) gained 25.1% to $1.0699 after the company announced the completion of its previously announced acquisition of Naamche.</li>
<li>Dave Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAVE#NYSE">DAVE</a>) gained 25% to $58.20 after the company reported better-than-expected first-quarter financial results and issued FY24 operating revenue.</li>
<li>Clearmind Medicine Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMND#NASDAQ">CMND</a>) surged 24.8% to $1.46 after the company signed an exclusive patent licensing agreement with Yissum Research Development Company.</li>
<li>Thoughtworks Holding, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TWKS#NASDAQ">TWKS</a>) jumped 22% to $3.0750 after the company issued strong guidance.</li>
<li>The Real Brokerage Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REAX#NASDAQ">REAX</a>) gained 21.5% to $5.07 following strong quarterly sales.</li>
<li>Global Self Storage, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SELF#NASDAQ">SELF</a>) rose 21.2% to $5.05.</li>
<li>Zeta Global Holdings Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZETA#NASDAQ">ZETA</a>) rose 21% to $15.72 after the company reported better-than-expected first-quarter financial results and increased its second-quarter revenue guidance.</li>
<li>Jumia Technologies AG (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JMIA#NASDAQ">JMIA</a>) climbed 19.3% to $6.53 after the company reported a year-over-year increase in first-quarter revenue results.</li>
<li>Bandwidth Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BAND#NASDAQ">BAND</a>) gained 19.2% to $24.45 after the company reported better-than-expected first-quarter financial results and issued FY24 revenue guidance above estimates.</li>
<li>ADTRAN Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADTN#NASDAQ">ADTN</a>) climbed 18.4% to $5.58 following upbeat quarterly results.</li>
<li>Jumia Technologies AG (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JMIA#NASDAQ">JMIA</a>) gained 18.3% to $6.47 after the company reported a year-over-year increase in first-quarter revenue results.</li>
<li>Ambac Financial Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMBC#NYSE">AMBC</a>) shares rose 16.5% to $17.64 following better-than-expected first-quarter earnings.</li>
<li>FibroGen, Inc.  (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FGEN#NASDAQ">FGEN</a>) gained 15.5% to $1.34 after the company reported mixed first-quarter financial results.</li>
<li>Sterling Infrastructure, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STRL#NASDAQ">STRL</a>) rose 15.1% to $121.27 after the company reported better-than-expected first-quarter financial results.</li>
<li>Coca-Cola Consolidated, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COKE#NASDAQ">COKE</a>) jumped 14.5% to $981.96 following first-quarter results.</li>
<li>Fabrinet (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FN#NYSE">FN</a>) gained 14% to $215.29 after the company reported better-than-expected third-quarter financial results and issued fourth-quarter adjusted EPS guidance above estimates.</li>
<li>J&amp;J Snack Foods Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JJSF#NASDAQ">JJSF</a>) gained 13.5% to $156.51 following better-than-expected quarterly results.</li>
<li>Artivion, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AORT#NYSE">AORT</a>) gained 13.4% to $23.90 following strong quarterly results.</li>
<li>EverQuote, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVER#NASDAQ">EVER</a>) gained 12.7% to $24.09 after the company reported better-than-expected first quarter financial results and issued second quarter revenue guidance above estimates.</li>
<li>Air Transport Services Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATSG#NASDAQ">ATSG</a>) rose 12.7% to $14.94 following upbeat earnings.</li>
<li>Surgery Partners, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGRY#NASDAQ">SGRY</a>) gained 9.3% to $27.98 following upbeat earnings.</li>
<li>Crocs, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CROX#NASDAQ">CROX</a>) climbed 8.6% to $137.52 following first quarter financial results.</li>
<li>Symbotic Inc.  (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SYM#NYSE">SYM</a>) shares rose 8.1% to $45.33 after the company reported mixed second-quarter financial results.</li>
<li>UBS Group AG (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBS#NYSE">UBS</a>) shares gained 8% to $29.81 after the company posted better-than-expected results for its first quarter.</li>
<li>Hims &amp; Hers Health, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIMS#NYSE">HIMS</a>) shares gained 6.9% to $12.45 after the company reported better-than-expected first-quarter financial results and issued FY24 revenue guidance above estimates.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Holdco Nuvo Group D.G Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUVO#NASDAQ">NUVO</a>) fell 39.2% to $3.1999 after jumping 157% on Monday.</li>
<li>The Real Good Food Company, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGF#NASDAQ">RGF</a>) dipped 32.6% to $0.5312.</li>
<li>Neuronetics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STIM#NASDAQ">STIM</a>) fell 32.5% to $2.5281 following quarterly results.</li>
<li>AgriFORCE Growing Systems Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGRI#NASDAQ">AGRI</a>) shares fell 27.4% to $0.1048 after the company announced an offering of 432.5 million shares by selling stockholders.</li>
<li>Strong Global Entertainment, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SGE#NYSE">SGE</a>) fell 27.4% to $1.9201. Fundamental Global announced acquisition of Strong/MDI Screen Systems, Inc. by FG Acquisition Corp. at a $30 million valuation.</li>
<li>GreenPower Motor Company Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GP#NASDAQ">GP</a>) shares declined 25.6% to $1.35 after the company reported pricing of $2.3 million underwritten public offering.</li>
<li>JELD-WEN Holding, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JELD#NYSE">JELD</a>) fell 23.5% to $14.56 as the company posted downbeat quarterly sales and lowered 2024 revenue guidance.</li>
<li>Oriental Culture Holding LTD (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OCG#NASDAQ">OCG</a>) dipped 22.6% to $1.2001.</li>
<li>BT Brands, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTBD#NASDAQ">BTBD</a>) fell 21.4% to $1.25.</li>
<li>Plutonian Acquisition Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTN#NASDAQ">PLTN</a>) shares fell 19.3% to $11.41 after surging 57% on Monday.</li>
<li>Talkspace, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TALK#NASDAQ">TALK</a>) fell 18.3% to $2.60 following first-quarter results.</li>
<li>Helius Medical Technologies, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSDT#NASDAQ">HSDT</a>) shares declined 16.2% to $2.03 after the company announced pricing of $6.4 million public offering.</li>
<li>Paymentus Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PAY#NYSE">PAY</a>) fell 15.5% to $18.76 following first-quarter results.</li>
<li>Myers Industries, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MYE#NYSE">MYE</a>) declined 15.5% to $19.43 following first-quarter results.</li>
<li>Builders FirstSource, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLDR#NYSE">BLDR</a>) dipped 15.4% to $170.00 following first-quarter earnings.</li>
<li>Palantir Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NYSE">PLTR</a>) fell 14.3% to $21.56 following soft revenue guidance.</li>
<li>AudioCodes Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUDC#NASDAQ">AUDC</a>) shares fell 13% to $9.89 after the company reported worse-than-expected <a href="https://www.benzinga.com/quote/AUDC/earnings">first-quarter financial results</a></li>
<li>First Watch Restaurant Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FWRG#NASDAQ">FWRG</a>) dipped 12.6% to $21.96 following weak quarterly sales.</li>
<li>Teradata Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDC#NYSE">TDC</a>) dipped 11.4% to $33.63 after the company reported mixed first-quarter financial results and issued second-quarter guidance.</li>
<li>Lucid Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LCID#NASDAQ">LCID</a>) shares fell 11.2% to $2.71 after the company reported mixed first-quarter financial results.</li>
<li>The Walt Disney Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIS#NYSE">DIS</a>) dipped 9.6% to $105.28 following a second-quarter revenue miss.</li>
<li>Methode Electronics, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MEI#NYSE">MEI</a>) fell 9.4% to $11.37. Methode Electronics named Kevin Nystrom as interim CEO, effective immediately.</li>
<li>Datadog, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DDOG#NASDAQ">DDOG</a>) fell 8.9% to $115.57 following first-quarter results.</li>
<li>Air Lease Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AL#NYSE">AL</a>) dipped 7.8% to $47.49 following weak quarterly sales.</li>
<li>Perrigo Company plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRGO#NYSE">PRGO</a>) fell 6.3% to $31.32 following weak quarterly sales.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/05/38670858/dow-surges-over-50-points-disney-earnings-top-views">Dow Surges Over 50 Points; Disney Earnings Top Views</a>

Why Beyond Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

American Strategic Investment Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NYC#NYSE">NYC</a>) (&quot;ASIC&quot; or the &quot;Company&quot;) announced today that it completed one new license agreement in the&nbsp;first quarter&nbsp;for approximately 8,000 square feet, resulting in a portfolio occupancy of&nbsp;87.2%. Additionally, the Company&#39;s leasing pipeline totals approximately 14,000 square feet.

American Strategic Investment Co. Secures New Lease, Boosting Portfolio Occupancy to 87.2%

American Strategic (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NYC#NYSE">NYC</a>) reported quarterly losses of $(0.52) per share which missed the analyst consensus estimate of $(0.07) by 642.86 percent. This is a 372.73 percent decrease over losses of $(0.11) per share from the same period last year. The company reported quarterly sales of $15.38 million which missed the analyst consensus estimate of $16.53 million by 6.96 percent. This is a 5.04 percent decrease over sales of $16.20 million the same period last year.

American Strategic Q4 EPS $(0.52) Misses $(0.07) Estimate, Sales $15.38M Miss $16.53M Estimate

<h3>Companies Reporting Before The Bell</h3>
&bull; Mach Natural Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MNR#NYSE">MNR</a>) is projected to report quarterly earnings at $0.92 per share on revenue of $213.43 million.
&bull; Sharps Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STSS#NASDAQ">STSS</a>) is expected to report earnings for its fourth quarter.
&bull; Sachem Cap (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SACH#AMEX">SACH</a>) is projected to report quarterly earnings at $0.11 per share on revenue of $16.58 million.
&bull; Enservco (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ENSV#AMEX">ENSV</a>) is projected to report quarterly loss at $0.05 per share on revenue of $6.60 million.
&bull; NexGel (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXGL#NASDAQ">NXGL</a>) is likely to report quarterly loss at $0.11 per share on revenue of $1.38 million.
&bull; Milestone Scientific (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MLSS#AMEX">MLSS</a>) is likely to report earnings for its fourth quarter.
&bull; SPAR Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGRP#NASDAQ">SGRP</a>) is estimated to report earnings for its fourth quarter.
&bull; Escalade (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ESCA#NASDAQ">ESCA</a>) is estimated to report earnings for its fourth quarter.
&bull; LogicMark (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGMK#NASDAQ">LGMK</a>) is likely to report quarterly loss at $1.73 per share on revenue of $2.28 million.
&bull; Jaguar Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JAGX#NASDAQ">JAGX</a>) is projected to report earnings for its fourth quarter.
&bull; Crown ElectroKinetics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRKN#NASDAQ">CRKN</a>) is expected to report earnings for its fourth quarter.
&bull; LM Funding America (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LMFA#NASDAQ">LMFA</a>) is estimated to report earnings for its fourth quarter.
&bull; DecisionPoint Sys (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/DPSI#AMEX">DPSI</a>) is expected to report earnings for its fourth quarter.
&bull; Edible Garden AG (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EDBL#NASDAQ">EDBL</a>) is estimated to report earnings for its fourth quarter.
&bull; Laser Photonics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LASE#NASDAQ">LASE</a>) is expected to report earnings for its fourth quarter.
&bull; Terran Orbital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLAP#NYSE">LLAP</a>) is estimated to report quarterly loss at $0.20 per share on revenue of $32.81 million.
&bull; Sigma Lithium (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGML#NASDAQ">SGML</a>) is expected to report quarterly earnings at $0.18 per share on revenue of $105.82 million.
&bull; Vislink Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VISL#NASDAQ">VISL</a>) is estimated to report earnings for its fourth quarter.
&bull; Nano X Imaging (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NNOX#NASDAQ">NNOX</a>) is projected to report quarterly loss at $0.30 per share on revenue of $2.82 million.
&bull; Ondas Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONDS#NASDAQ">ONDS</a>) is estimated to report quarterly loss at $0.14 per share on revenue of $4.27 million.
&bull; TriSalus Life Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLSI#NASDAQ">TLSI</a>) is projected to report quarterly loss at $0.69 per share on revenue of $5.45 million.
&bull; Venus Concept (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERO#NASDAQ">VERO</a>) is projected to report quarterly loss at $1.18 per share on revenue of $22.45 million.
<h3>Companies Reporting After The Bell</h3>
&bull; BurgerFi International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BFI#NASDAQ">BFI</a>) is expected to report quarterly loss at $0.19 per share on revenue of $40.00 million.
&bull; AST SpaceMobile (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASTS#NASDAQ">ASTS</a>) is expected to report earnings for its fourth quarter.
&bull; PVH (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PVH#NYSE">PVH</a>) is expected to report quarterly earnings at $3.53 per share on revenue of $2.42 billion.
&bull; VirTra (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VTSI#NASDAQ">VTSI</a>) is projected to report quarterly earnings at $0.15 per share on revenue of $9.37 million.
&bull; Motorsport Games (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSGM#NASDAQ">MSGM</a>) is estimated to report earnings for its fourth quarter.
&bull; Yield10 Bioscience (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YTEN#NASDAQ">YTEN</a>) is estimated to report quarterly loss at $0.30 per share on revenue of $30 thousand.
&bull; OMNIQ (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OMQS#NASDAQ">OMQS</a>) is likely to report quarterly loss at $0.26 per share on revenue of $16.35 million.
&bull; FlexShopper (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FPAY#NASDAQ">FPAY</a>) is projected to report quarterly loss at $0.25 per share on revenue of $30.51 million.
&bull; Stryve Foods (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNAX#NASDAQ">SNAX</a>) is estimated to report quarterly loss at $1.96 per share on revenue of $5.01 million.
&bull; Air Industries (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AIRI#AMEX">AIRI</a>) is expected to report quarterly loss at $0.34 per share on revenue of $12.40 million.
&bull; Eastside Distilling (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EAST#NASDAQ">EAST</a>) is expected to report quarterly loss at $0.90 per share on revenue of $3.68 million.
&bull; BIO-key Intl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKYI#NASDAQ">BKYI</a>) is expected to report earnings for its fourth quarter.
&bull; SKYX Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SKYX#NASDAQ">SKYX</a>) is likely to report quarterly loss at $0.08 per share on revenue of $21.12 million.
&bull; Omeros (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OMER#NASDAQ">OMER</a>) is projected to report earnings for its fourth quarter.
&bull; Natural Gas Services Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NGS#NYSE">NGS</a>) is estimated to report quarterly earnings at $0.06 per share on revenue of $30.30 million.
&bull; TOMI Environmental Solns (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TOMZ#NASDAQ">TOMZ</a>) is expected to report quarterly loss at $0.01 per share on revenue of $2.86 million.
&bull; Canoo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOEV#NASDAQ">GOEV</a>) is likely to report quarterly loss at $1.77 per share on revenue of $700 thousand.
&bull; GSE Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GVP#NASDAQ">GVP</a>) is likely to report quarterly loss at $0.81 per share on revenue of $12.07 million.
&bull; Acorda Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACOR#NASDAQ">ACOR</a>) is likely to report earnings for its fourth quarter.
&bull; Protagenic Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTIX#NASDAQ">PTIX</a>) is projected to report earnings for its fourth quarter.
&bull; SHF Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHFS#NASDAQ">SHFS</a>) is likely to report earnings for its fourth quarter.
&bull; Ideanomics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IDEX#NASDAQ">IDEX</a>) is likely to report earnings for its fourth quarter.
&bull; American Strategic (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NYC#NYSE">NYC</a>) is estimated to report quarterly loss at $0.07 per share on revenue of $16.53 million.
&bull; Zomedica (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ZOM#AMEX">ZOM</a>) is expected to report earnings for its fourth quarter.
&bull; Microvast Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MVST#NASDAQ">MVST</a>) is estimated to report quarterly loss at $0.07 per share on revenue of $94.43 million.
&bull; Paymentus Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PAY#NYSE">PAY</a>) is projected to report quarterly earnings at $0.11 per share on revenue of $50.27 million.
&bull; IZEA Worldwide (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IZEA#NASDAQ">IZEA</a>) is projected to report quarterly loss at $0.07 per share on revenue of $10.00 million.
&bull; Duos Technologies Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DUOT#NASDAQ">DUOT</a>) is expected to report quarterly loss at $0.25 per share on revenue of $3.00 million.
&bull; Pioneer Power Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PPSI#NASDAQ">PPSI</a>) is expected to report quarterly earnings at $0.01 per share on revenue of $10.89 million.
This article was generated by Benzinga&#39;s automated content engine and reviewed by an editor.

ACOR

AIRI

ASTS

BKYI

CRKN

DPSI

DUOT

EAST

EDBL

ENSV

ESCA

FPAY

GOEV

IDEX

IZEA

JAGX

LASE

LGMK

LLAP

LMFA

MLSS

MVST

NNOX

NXGL

OMER

OMQS

ONDS

PPSI

PTIX

SACH

SGML

SGRP

SHF Holdings, Inc. - Class A Common Stock

SHFS

SKYX

SNAX

STSS

TLSI

TOMZ

VERO

VISL

VTSI

YTEN

Earnings Scheduled For April 1, 2024

When a market sector begins to see a pickup in insider buying, that's generally a positive sign, indicating that the sector is considered undervalued and showing signs of improving returns in the future. Insiders may sell stock for any number of reasons, but they almost always buy shares because they believe in the prospects of their company.
Recently, insider purchases of real estate investment trusts (REITs) have been on the rise, as company officials sense share prices have stabilized and are at attractive levels. A two-meeting pause of interest rate hikes by the Federal Reserve has also helped secure a bottom in numerous REITs with declining share prices.
<h2 class="wp-block-heading">Don't Miss:</h2>
<ul>
<li>Most investors are priced out of buying real estate in the highest-growth markets, but they can <a href="https://www.benzinga.com/money/most-investors-are-priced-out-of-buying-real-estate-in-areas-of-accelerated-growth-but-they-can-still-profit-from-it-through-one-innovative-platform">still get a piece of the action through this innovative strategy.</a>&nbsp;</li>
<li>Elon Musk has reportedly bought 6,000 acres of land just outside of Austin.<a href="https://www.benzinga.com/real-estate/23/05/32537165/elon-musk-is-bullish-on-austin-heres-how-to-invest-in-the-citys-growth-before-he-floods-it-with-new"> Here&#8217;s how to invest in the city&#8217;s growth</a> before he floods it with new tech workers.</li>
</ul>
Take a look at five REITs with recent insider buying that could be a tip-off that better times are ahead.
Arbor Realty Trust Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABR#NYSE">ABR</a>) is a Long Island, New York-based mortgage REIT (mREIT) that initiates bridge and mezzanine loans for commercial and residential properties. Many of its loans originate through Fannie Mae and Freddie Mac programs.
Arbor Realty Trust generates profits by the spread between the cost of financing a loan and the interest earned from that loan. Many of Arbor Realty Trust's commercial loans are first mortgage liens that are short term with higher interest rates.
On Nov. 8, Chairman and CEO Ivan Kaufman bought 10,000 shares of Arbor Realty Trust common stock in a transaction totaling $124,700.
On Nov. 16, Viceroy Research issued a highly critical report on Arbor Realty and discussed the reasons for its short position on the mREIT. Shares plunged over 8% after the report was released.
The same day, and perhaps to counter Viceroy's claims, Arbor Realty Chief Financial Officer Paul Elenio showed his faith in the company by purchasing 7,500 shares of stock at an average price of $12.37, giving him a total of 277,299 shares.
A recent closing price for Arbor Realty Trust was $12.19, slightly below Elenio's purchase price.
American Strategic Investment Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NYC#NYSE">NYC</a>) is a New York-based diversified REIT with eight office and retail condominium assets in Manhattan and surrounding areas. As of Sept. 30, it had an 85.1% weighted occupancy with remaining lease terms of 6.6 years.
On Nov. 17, New York City Advisors, a 10% owner of American Strategic, bought 1,536 shares of company stock at an average price of $7.96 per share. The total cost was approximately $12,226.
American Strategic recently closed at $8.17.
Bluerock Homes Trust Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BHM#NYSE">BHM</a>) is a New York-based, externally managed residential REIT that buys and rents single-family homes in the Sun Belt and Western portions of the U.S. Bluerock owns over 50 million square feet of residential real estate worth more than $15 billion. Bluerock Homes Trust was originally part of Bluerock Residential Growth REIT Inc., which began in 2008. Bluerock Homes Trust was spun off in September 2022 with an initial public offering (IPO).
On Nov. 17, CFO and Treasurer Christopher J. Vohs purchased 12,000 shares of company stock near the IPO price of $22.50, for a total of $270,000. Vohs now owns 24,000 shares of company stock.
The most recent closing price for Bluerock Homes was $14.89, so an investor buying shares today would be purchasing shares below this insider's initial price.
Four Corners Property Trust Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FCPT#NYSE">FCPT</a>) is a Mill Valley, California-based diversified REIT, with a focus on owning restaurants, healthcare and other retail properties in the Sun Belt regions of the U.S.
Over the past seven years, Four Corners has reduced its original stake of 418 restaurants, spun out from Darden Restaurants Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DRI#NYSE">DRI</a>), and has steadily acquired more diversified properties. Its portfolio includes 1,106 long-term leased properties with 148 brands across 47 states. Its occupancy and rental rates were 99.8% with a weighted annual lease term (WALT) of eight years.
On Nov. 7, director Douglas B. Hansen purchased 4,950 shares of Four Corners common stock for $21.74, partially by a trust, presently giving him a total of 59,061 shares of common stock.
The most recent closing price for Four Corners was $22.75.
On Oct. 25, Modiv Industrial Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MDV#NYSE">MDV</a>) director Thomas H. Nolan Jr. purchased 121.2553 shares of Modiv common stock at $14.49, for a total price of $1,756.98. Nolan now owns 18,524.82 shares.
Modiv has been one of the best-performing REITs year to date, with a total return of 36.41%. Its most recent closing price was $15.41.
Note to investors: While insider purchases are a signal that company officials believe in the long-term value of their stock, insiders don't always buy at the absolute bottom and there can still be short-term losses. Investors should always perform due diligence on REITs and never make any purchases solely based on insider activity.
Weekly REIT Report: REITs are one of the most misunderstood investment options, making it difficult for investors to spot incredible opportunities until it's too late. Benzinga's in-house real estate research team has been working hard to identify the greatest opportunities in today's market, which you can gain access to for free by signing up for the <a href="https://www.benzinga.com/money/reit-newsletter">Weekly REIT Report.</a>
<h2 class="wp-block-heading">Read Next:</h2>
<ul>
<li>Homeownership may be out of reach for most Americans, but that&#8217;s not stopping these average investors from raking in <a href="https://www.benzinga.com/money/bezos-landlord-100-dollars">passive income through shares of single-family rentals</a>.</li>
<li>Passive income investments are one of the most trusted methods for riding out a recession, so it's no surprise that people are turning to <a href="https://www.benzinga.com/real-estate/23/05/32554601/want-to-grow-your-wealth-passively-these-high-yield-real-estate-notes-might-be-your-holy-grail">high-yield real estate notes that pay a fixed 7.5% to 9%.</a></li>
</ul>

REIT

Real Estate

Bluerock Homes Trust, Inc. Class A Common Stock

FCPT

5 REITs With Recent Insider Buying

American Strategic (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NYC#NYSE">NYC</a>) reported quarterly losses of $(0.48) per share. This is a 57.14 percent increase over losses of $(1.12) per share from the same period last year. The company reported quarterly sales of $16.02 million which missed the analyst consensus estimate of $16.39 million by 2.29 percent. This is a 0.52 percent increase over sales of $15.93 million the same period last year.

American Strategic Q3 Core FFO $(0.48) Up From $(1.12) YoY, Sales $16.02M Miss $16.39M Estimate

Although U.S. stocks closed higher on Thursday, there were a few notable insider trades.
When insiders purchase shares, it indicates their confidence in the company&#39;s prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.
Below is a look at a few recent notable insider purchases. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/"> Benzinga&#39;s insider transactions </a> platform.
<h3>Barnes Group </h3>
<ul>
<li>The Trade: Barnes Group Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/b#NYSE">B</a>) President and CEO Thomas J Hook <a href="https://www.benzinga.com/quote/B/analyst-ratings"> acquired a total of 125,000 shares </a> an average price of $20.98. To acquire these shares, it cost around $2.62 million.</li>
<li>What&rsquo;s Happening: Barnes Group reported worse-than-expected third-quarter adjusted EPS results and lowered FY23 adjusted EPS guidance below estimates.</li>
<li>What Barnes Group Does: Barnes Group Inc is a U.S. based industrial and aerospace manufacturer and service provider. The company operates through two segments: Industrial and Aerospace.</li>
</ul>
<h3>Mobileye Global </h3>
<ul>
<li>The Trade: Mobileye Global Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mbly#NASDAQ">MBLY</a>) Director Claire McCaskill acquired a total of 27,819 shares at an average price of $35.95. To acquire these shares, it cost around $1 million.</li>
<li>What&rsquo;s Happening: Mobileye Global posted upbeat earnings for the third quarter.</li>
<li>What Mobileye Global Does: Mobileye Global Inc engages in the development and deployment of ADAS and autonomous driving technologies and solutions.</li>
</ul>
Don&rsquo;t forget to check out our <a href="https://www.benzinga.com/premarket/"> premarket coverage here </a> 
<h3>American Strategic Investment </h3>
<ul>
<li>The Trade: American Strategic Investment Co. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nyc#NYSE">NYC</a>) 10% owner New York City Advisors LLC <a href="https://www.benzinga.com/sec/insider-trades/"> bought a total of 223,460 shares </a> at an average price of $10.25. To acquire these shares, it cost around $2.29 million.</li>
<li>What&rsquo;s Happening: American Strategic Investment completed the sale of the property it owns at 421 W. 54Th Street (The Hit Factory) for $4.5 million.</li>
<li>What American Strategic Investment Does: American Strategic Investment Co is an externally managed company that currently owns a portfolio of commercial real estate located within the five boroughs of New York City, majorly Manhattan.</li>
</ul>
<h3>Donegal Group </h3>
<ul>
<li>The Trade: Donegal Group Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dgica#NASDAQ">DGICA</a>) 10% owner Donegal Mutual Insurance Co <a href="https://www.benzinga.com/sec/insider-trades/"> bought a total of 13,545 shares </a> at an average price of $14.24. The insider spent around $192,935 to buy those shares.</li>
<li>What&rsquo;s Happening: Donegal posted weaker-than-expected earnings for its third quarter.</li>
<li>What Donegal Group Does: Donegal Group Inc is an insurance holding company that offers personal and commercial lines of property and casualty insurance to businesses and individuals.</li>
</ul>
&nbsp;
Check This Out: <a href="https://www.benzinga.com/news/earnings/23/11/35584496/apple-skyworks-solutions-and-3-stocks-to-watch-heading-into-friday"> Apple, Skyworks Solutions And 3 Stocks To Watch Heading Into Friday </a>

Small Cap

DGICA

MBLY

$1M Bet On Mobileye Global? Check Out These 4 Stocks Insiders Are Buying

General

American Strategic Investment Completed The Sale Of The Property It Owns At 421 W. 54Th Street (The Hit Factory) For $4.5M

American Strategic Investment Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NYC#NYSE">NYC</a>) (&quot;ASIC&quot; or the &quot;Company&quot;) announced today that it has filed with the Securities and Exchange Commission (&quot;SEC&quot;) a Solicitation/Recommendation Statement on Schedule 14D-9 and Letter to Stockholders dated October 10, 2023, regarding the tender offer commenced by Bellevue Capital Partners, LLC (&quot;Bellevue&quot;) on September 27, 2023, to purchase up to 350,000 shares of the Company&#39;s Class A common stock at a price of&nbsp;$10.25&nbsp;per share (the &quot;Tender Offer&quot;). The Company&#39;s board of directors has made no determination of the fairness of the Tender Offer or whether it is in the best interests of stockholders, makes no recommendation and is neutral as to whether stockholders should accept or reject the offer to tender their shares. The Company urges each stockholder to review the Schedule 14D-9 and the accompanying Letter to Stockholders as well as the tender offer materials sent by Bellevue and to make its own decision regarding the Tender Offer based on the available information. The Tender Offer will expire at 11:59 PM, New York City time, on October 26, 2023, unless extended or earlier terminated by Bellevue.

American Strategic Investment Co Files with SEC, Leaves Stockholders to Evaluate Bellevue's $10.25 Per Share Offer

Investors are constantly on the hunt for undervalued, under-followed, and emerging stocks. With countless methods available to retail traders, the challenge often lies in sifting through the abundance to uncover new information.
Benzinga&rsquo;s Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks each week that are just under the surface and warrant attention.
The index layers editorial commentary to help make sense of why these stocks should be of interest and whether investors and casual readers should watch them.
Here is a look at the Benzinga Stock Whisper Index for the week of Sept. 29, 2023.
See Also: <a href="https://www.benzinga.com/quote/BHVN/analyst-ratings">Analyst Ratings For Biohaven</a>
<ul>
<li>Biohaven Ltd (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bhvn#NYSE">BHVN</a>): Clinical stage biotechnology company Biohaven, which is a subsidiary of Pfizer Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pfe#NYSE">PFE</a>), saw shares soar after<a href="https://www.benzinga.com/general/biotech/23/09/34955283/whats-going-on-pfizers-subsidiary-biohaven-stock"> releasing an updated</a> investor presentation and sharing an update on one of the company&rsquo;s key clinical programs. The company said its BHV-1300 shows a substantial reduction in IgG levels, which is superior to rival programs. Biohaven shares are up 74% year-to-date in 2023 and are up over 50% in the last week.</li>
<li>Nikola Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nkla#NASDAQ">NKLA</a>): Shares of the electric and hydrogen vehicle company continue to see increased attention from investors. The company has<a href="https://www.benzinga.com/news/23/09/34923157/whats-going-on-with-nikola-stock-today"> announced several new</a> executives joining the team and signed a deal with ITD Industries, who will be the company&rsquo;s first dealer for its Class 8 EV trucks in Canada. Shares of Nikola are down 60% in the last year. Over the last month, shares of Nikola have risen over 30% with investors appearing impressed with the latest news flow.</li>
<li>ShiftPixy Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pixy#NASDAQ">PIXY</a>): The staffing enterprise company saw shares soar on Wednesday after <a href="https://www.benzinga.com/news/23/09/34950373/why-shiftpixy-stock-pixy-is-exploding-150-higher">announcing an effective date</a> for a reverse split on shares. The low float company will conduct a 1-for-24 reverse stock split on Oct. 2, 2023. Companies that have conducted reverse stock splits and lowered their share floats have been popular trades among retail investors. Shares of ShiftPixy are down over 90% year-to-date in 2023.</li>
<li>MillerKnoll Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mlkn#NASDAQ">MLKN</a>): Earlier this year, the furniture and accessory company made headlines when CEO Andi Owen told disgruntled employees to &ldquo;leave pity city&rdquo; and<a href="https://www.benzinga.com/news/23/04/31861669/millerknoll-ceo-tells-employees-to-get-the-damn-26-million-and-leave-pity-city-goes-viral"> criticized those </a>who were worried about staying motivated if they don&rsquo;t get bonuses. &ldquo;Don&rsquo;t ask what are we gonna do if we don&rsquo;t get a bonus, get the damn $26 million,&rdquo; Owen said of a revenue shortcoming. First quarter earnings per share and revenue <a href="https://www.benzinga.com/news/23/09/34926268/why-millerknoll-stock-surged-after-hours">beat estimates</a> from analysts. The company also raised its full year earnings per share estimate and guidance was well received by investors.</li>
<li>American Strategic Investment Co (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nyc#NYSE">NYC</a>): The commercial real estate company saw shares climb after it was announced that Bellevue Capital Partners launched a tender offer to buy up to 350,000 shares of the company for $10.25. This marked a 65% premium to where shares of American Strategic were trading at the time.</li>
</ul>
Check out the most recent Stock Whisper reports here:
<a href="https://www.benzinga.com/news/23/09/34362648/benzingas-stock-whisper-index-5-stocks-investors-are-secretly-monitoring-but-not-talking-about-yet">Sept. 8</a>
<a href="https://www.benzinga.com/markets/penny-stocks/23/09/34617260/benzingas-stock-whisper-index-5-stocks-investors-are-secretly-monitoring-but-not-talking-abo">Sept. 15</a>
<a href="https://www.benzinga.com/markets/penny-stocks/23/09/34823682/benzingas-stock-whisper-index-5-stocks-investors-are-secretly-monitoring-but-not-talking-abo">Sept. 22</a>
Stay tuned for next week&rsquo;s report, and follow Benzinga Pro for all the latest headlines and<a href="https://pro.benzinga.com/feature/newsfeed/?gspk=bHVrZWphY29iaTUzNDg&amp;gsxid=tdEE0VrK8Jeg&amp;ref=lukejacobi5348"> top market-moving stories here.</a>
Read Next: <a href="https://www.benzinga.com/news/23/04/31919688/ceo-who-told-employees-to-leave-pity-city-offers-apology-for-rallying-cry-employees-tell-media-they">CEO Who Told Employees To Leave Pity City Offeres Apology For Rallying Cry</a> 
&nbsp;

Penny Stocks

Exclusives

BHVN

MLKN

NKLA

PIXY

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring But Not Talking About Yet

<h3>Gainers</h3>
<ul>
<li>ShiftPixy, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pixy#NASDAQ">PIXY</a>) shares jumped 152.8% to $1.09. The company announced the effective date for its reverse stock split after the close. Shareholders voted to approve a reverse split on Aug. 21. After the closing bell on Tuesday, ShiftPixy said the one-for-twenty-four reverse split will take effect on Sept. 30.</li>
<li>SciSparc Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sprc#NASDAQ">SPRC</a>) gained 120.9% to $0.3450. The company reported its previously announced 1-for-26 reverse share split is expected to be implemented after market close today.</li>
<li>Rite Aid Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rad#NYSE">RAD</a>) climbed 44% to $0.6175. Consulting firm McKinsey &amp; Company has reached a substantial settlement agreement of $230 million to resolve lawsuits filed by numerous U.S. local governments and school districts, accusing the firm of contributing to the opioid addiction crisis through its consulting work with OxyContin maker Purdue Pharma and other pharmaceutical companies.</li>
<li>MillerKnoll, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mlkn#NASDAQ">MLKN</a>) surged 27% to $24.31 after the company announced better-than-expected first-quarter financial results and issued FY24 EPS guidance above estimates.</li>
<li>Biohaven Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bhvn#NYSE">BHVN</a>) shares gained 24.6% to $21.99.</li>
<li>American Strategic Investment Co. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nyc#NYSE">NYC</a>) climbed 22.8% to $7.64 after Bellevue Capital Partners, LLC launched a tender offer for shares of the company.</li>
<li>Inpixon (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/inpx#NASDAQ">INPX</a>) gained 18.4% to $0.1512.</li>
<li>MSP Recovery, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lifw#NASDAQ">LIFW</a>) shares climbed 18.3% to $0.1799 after falling around 25% on Tuesday.</li>
<li>Gaucho Group Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vino#NASDAQ">VINO</a>) gained 18.2% to $2.4699 after falling over 12% on Tuesday. Gaucho Group recently announced a 1-for-10 reverse stock split.</li>
<li>Galecto, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/glto#NASDAQ">GLTO</a>) shares climbed 17.3% to $0.6740 after the company announced plans to explore strategic alternatives.</li>
<li>Phoenix New Media Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/feng#NYSE">FENG</a>) climbed 16% to $1.3004 as the company announced up to $2 million share repurchase program.</li>
<li>Ramaco Resources, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/metc#NASDAQ">METC</a>) rose 15.3% to $10.77.</li>
<li>SoundHound AI, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/soun#NASDAQ">SOUN</a>) gained 15% to $1.84 after DA Davidson initiated coverage on the stock with a Buy rating and $5 price target.</li>
<li>VBI Vaccines Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vbiv#NASDAQ">VBIV</a>) rose 14% to $0.7142 as the company Announced interim data from the Phase 1 study of its multivalent pan-coronavirus vaccine candidate, VBI-2901.</li>
<li>Finance Of America Companies Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/foa#NYSE">FOA</a>) gained 14% to $1.39.</li>
<li>Advanced Emissions Solutions, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ades#NASDAQ">ADES</a>) climbed 11.7% to $1.7095.</li>
<li>Warrior Met Coal, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hcc#NYSE">HCC</a>) surged 10.5% to $51.93.</li>
<li>Immunovant, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/imvt#NASDAQ">IMVT</a>) climbed 10.2% to $44.04 as the company reported a proposed offering of $300 million of common stock.</li>
<li>PROS Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pro#NYSE">PRO</a>) surged 9.4% to $35.00. PROS Holdings is working with Qatalyst Partners to explore a sale, Reuters reported.</li>
<li>WW International, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ww#NASDAQ">WW</a>) gained 7.2% to $11.03. Craig-Hallum upgraded WW International from Sell to Hold.</li>
<li>Cardiff Oncology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/crdf#NASDAQ">CRDF</a>) shares gained 7% to $1.73 after the company announced clinical data in pancreatic cancer and small cell lung cancer, including single-agent activity from onvansertib monotherapy.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>mCloud Technologies Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mcld#NASDAQ">MCLD</a>) shares dipped 45.5% to $0.1569 after the company said it would not meet the listing requirements of the Nasdaq Stock Market LLC.</li>
<li>Know Labs, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/knw#NYSE">KNW</a>) fell 32.3% to $0.24 after the company announced pricing of a $7 million public offering of common stock.</li>
<li>Sharps Technology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/stss#NASDAQ">STSS</a>) fell 31.6% to $0.56 after the company reported a $5.6 million registered direct and private placement priced at the market under Nasdaq rules.</li>
<li>XWELL, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xwel#NASDAQ">XWEL</a>) dipped 29.9% to $0.1142. XWELL announced a 1-for-20 reverse stock split.</li>
<li>Minerva Surgical, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/utrs#NASDAQ">UTRS</a>) fell 29.6% to $0.1990 after jumping 55% on Tuesday.</li>
<li>Faraday Future Intelligent Electric Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ffie#NASDAQ">FFIE</a>) tumbled 26.4% to $1.8099 after the company announced an &quot;at-the-market&quot; equity offering program.</li>
<li>Femasys Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/femy#NASDAQ">FEMY</a>) dipped 25% to $1.11. Femasys shares jumped 346% on Tuesday after the company received FDA 510(k) clearance for FemaSeed, an infertility treatment.</li>
<li>Tharimmune, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/thar#NASDAQ">THAR</a>) fell 24.4% to $0.2222 after surging 33% on Tuesday.</li>
<li>Conduit Pharmaceuticals Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cdt#NASDAQ">CDT</a>) fell 19% to $5.32 after declining more than 36% on Tuesday.</li>
<li>Cheche Group Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ccg#NASDAQ">CCG</a>) declined 17.4% to $13.31.</li>
<li>NextEra Energy Partners, LP (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nep#NYSE">NEP</a>) fell 17.2% to $38.82 after the company announced it is revising its limited partner distribution per unit growth rate to 5% to 8% per year through at least 2026.</li>
<li>Soleno Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/slno#NASDAQ">SLNO</a>) tumbled 15.8% to $22.55.</li>
<li>Avinger, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/avgr#NASDAQ">AVGR</a>) fell 15.5% to $6.43. Avinger raised gross proceeds of approximately $5.3 million through its at-the-market, selling an aggregate of 596,200 shares at a weighted average price of $8.97.</li>
<li>DMK Pharmaceuticals Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dmk#NASDAQ">DMK</a>) declined 15.2% to $0.6499. The company was recently granted a Canadian patent titled &#39;An Opioid For Use To Reduce And/Or Treat Drug Addiction.&#39;</li>
<li>TransCode Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rnaz#NASDAQ">RNAZ</a>) fell 13.5% to $0.5969. TransCode Therapeutics recently priced its $8 million public offering of 15.7 million shares at $0.51/share.</li>
<li>Apellis Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/apls#NASDAQ">APLS</a>) declined 12% to $37.98.</li>
<li>American Oncology Network, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aonc#NASDAQ">AONC</a>) fell 11.3% to $11.63.</li>
<li>Axcella Health Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/axla#NASDAQ">AXLA</a>) fell 11% to $7.07 after declining around 10% on Tuesday.</li>
<li>VinFast Auto Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vfs#NASDAQ">VFS</a>) declined 9.3% to $11.68.</li>
<li>PolyPid Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pypd#NASDAQ">PYPD</a>) fell 9% to $4.8980 after declining 4% on Tuesday. PolyPid recently announced a successful Good Manufacturing Practice (GMP) audit by the Israeli Ministry of Health.</li>
<li>Traeger, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cook#NYSE">COOK</a>) fell 8.1% to $2.60. Morgan Stanley downgraded Traeger from Equal-Weight to Underweight and lowered the price target from $4.75 to $3.</li>
<li>AngloGold Ashanti Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/au#NYSE">AU</a>) declined 7.2% to $16.87.</li>
<li>Wabash National Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wnc#NYSE">WNC</a>) fell 7% to $20.60. DA Davidson downgraded Wabash National from Buy to Neutral and announced a $25 price target.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/markets/cryptocurrency/23/09/34949321/ethereum-tops-1-600-maker-injective-among-top-gainers"> Ethereum Tops $1,600; Maker, Injective Among Top Gainers</a>

ADES

AONC

APLS

AVGR

AXLA

COOK

CRDF

FEMY

FENG

FFIE

GLTO

IMVT

INPX

LIFW

MCLD

METC

PYPD

RNAZ

SLNO

SOUN

SPRC

THAR

UTRS

VBIV

VINO

XWEL

Why Sharps Technology Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

American Strategic Investment Co. shares are trading higher after Bellevue Capital Partners, LLC launched a tender offer for shares of the company.

New York City REIT (NYC) has provided an announcement. American Strategic Investment Co. has announced that it plans to sell its 9 Times Square pro...

New York City REIT Advances Sale of Times Square Property

American Strategic Investment intends to sell 9 Times Square property for $63.5M

The latest announcement is out from New York City REIT (NYC). American Strategic Investment Co. has released a press release on July 26, 2024, the ...

New York City REIT's Unfiled Strategic Investment Details

American Strategic Investment GAAP EPS of -$36.48, revenue of $15.75M

The latest update is out from New York City REIT (NYC). The company recently announced its operational results for the quarter ending June 30, 2024...

New York City REIT Outlines Quarterly Performance and Strategy

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

American Strategic

American Strategic (NYC) Forecast

American Strategic (NYSE:NYC) Stock, Quote.Headers.trade-ideas